August 20, 2003
Schering Corp Has Recalled Celestone
Soluspan Injectable Suspension
The Food and Drug Administration (FDA) released the following information.
Celestone Soluspan Injectable Suspension, USP, 6 mg/mL, (betamethasone
sodium phosphate and betamethasone acetate), 5mL Multiple-Dose Vial, Rx
Only. Recall # D-306-3.
Batch No. 2-AHU-12, Expiry June 2004.
Schering Corp, Kenilworth, NJ, by letter on July 10, 2003. Firm initiated
recall is ongoing.
Lack of assurance of sterility.
VOLUME OF PRODUCT IN COMMERCE